RAMANDEEP KAUR: Open Payments
NPI 1689268435 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 5 payments from 3 companies in 2025. Trend: 2023 $131 · 2024 $181 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 3 | $168 |
| Gilead Sciences, Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $14 |
Products named: Xhance, DUPIXENT.
Industry payments across TX — which companies pay providers there.
